COMPANY PROFILE / #3693
BrainScope
Rockville, MDVenture Capital-Backed
OVERVIEW
Developer of an artificial intelligence-powered brain health assessment platform designed to evaluate brain function and support neurological care. The company offers electroencephalography-based biomarkers, artificial intelligence-driven analytics, and a brain health assessment platform, enabling healthcare providers and consumer health users to assess traumatic brain injuries, cognitive impairment, and overall brain health with objective clinical insights.
已融资78.90
最新估值32.80
员工数20
成立年份2006
公司概况
- Companies
- BrainScope
- Description
- Developer of an artificial intelligence-powered brain health assessment platform designed to evaluate brain function and support neurological care. The company offers electroencephalography-based biomarkers, artificial intelligence-driven analytics, and a brain health assessment platform, enabling healthcare providers and consumer health users to assess traumatic brain injuries, cognitive impairment, and overall brain health with objective clinical insights.
- Website
- www.brainscope.com
- HQ Location
- Rockville, MD
- Year Founded
- 2006
- Keywords
- concussion detection, concussion test, diagnose neurological disorder, diagnostic insights, monitor neurological disorder, neurological technology device, neurological treatment, neurotechnology device, point-of-care testing, rapid testing, traumatic brain injury
- Competitors
- Beacon Biosignals, Cognision, ImPACT Applications, Oculogica, Head Diagnostics, BRAINBox Solutions, CNS Vital Signs, BrainCheck, NeuroPace, NanoDx, Cerora, Linus Health, Bio-Signal Group, InfraScan, Epitel, Ceribell, NeuraMetrix, Aural Analytics, EMOTIV, WinterLight Labs, NeuroServo, Sway Medical, Zeto (Monitoring Equipment)
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 78.90
- First Financing Date
- 26-Jun-2006
- First Financing Size
- 7.57
- First Financing Valuation
- —
- Last Financing Date
- 30-Jun-2026
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- —
- Last Financing Valuation
- —
- Last Financing Status
- Announced/In Progress
- Last Known Valuation
- 32.80
- Last Known Valuation Date
- 19-Sep-2023
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 36.79
- Valuation Estimate Growth Rate
- 12.17%
- Active Investors
- Aloha BS, Alzheimers Drug Discovery Foundation, Brain Trust Accelerator Fund, Bruin Capital, BSC Investors, CID Equity, DBL Partners, Difference Capital Financial, Draper Fisher Jurvetson Portage, GE Aerospace, Maryland Department of Commerce, Revolution (Washington DC), Stephen Case, TEDCO, United States Department of War
- # Active Investors
- 15
- Acquirers
- —
团队与联系人
- Employees
- 20
- Employee Growth %
- -45.95% E
- Employee History
- 2025: 20, 2024: 37 E, 2023: 53, 2022: 51, 2021: 30, 2020: 33
- Primary Contact
- Aaron DeGagne
- Primary Contact Title
- Manager, Corporate Development
- Primary Contact Email
- aaron.degagne@brainscope.com
- Primary Contact Phone
- +1 (240) 752-7680
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 11.46x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 94
- Majestic Referring Domains
- 298
- SimilarWeb Unique Visitors
- 185
- SimilarWeb Unique Visitors Change
- -114
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 15%
- Success Probability Over Time – 3 Year
- 31%
- Success Probability Over Time – 5 Year
- 45%
记录来源：public.companies · 原始序号 #3693 · 所有字段均按数据库原值展示。